Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · Real-Time Price · USD
12.30
+0.05 (0.41%)
At close: Nov 22, 2024, 4:00 PM
12.28
-0.02 (-0.18%)
After-hours: Nov 22, 2024, 5:20 PM EST

Avid Bioservices Revenue

Avid Bioservices had revenue of $40.17M in the quarter ending July 31, 2024, with 6.49% growth. This brings the company's revenue in the last twelve months to $142.36M, down -5.28% year-over-year. In the fiscal year ending April 30, 2024, Avid Bioservices had annual revenue of $139.91M, down -6.27%.

Revenue (ttm)
$142.36M
Revenue Growth
-5.28%
P/S Ratio
5.48
Revenue / Employee
$383,714
Employees
371
Market Cap
786.66M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 2024139.91M-9.36M-6.27%
Apr 30, 2023149.27M29.67M24.81%
Apr 30, 2022119.60M23.73M24.75%
Apr 30, 202195.87M36.17M60.58%
Apr 30, 202059.70M6.10M11.38%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.12B
Pacira BioSciences 694.96M
Avanos Medical 681.50M
Prothena Corporation 133.35M
Cronos Group 111.23M
AbCellera Biologics 32.96M
Relay Therapeutics 10.01M
Revenue Rankings